Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Rossi

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Cancer Genetics|October 12, 2015
A multicenter, cross-platform clinical validation study of cancer cytogenomic arraysMarilyn M Li, Federico A Monzon, Jaclyn A Biegel, et al.
NPJ Precision Oncology|November 13, 2018
Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathwaysSameer H Halani, Safoora Yousefi, Jose Velazquez Vega, et al.
Cancer Medicine|August 16, 2014
Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancerTaofeek K Owonikoko, Guojing Zhang, Xingming Deng, et al.
Cancer|June 14, 2017
Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapyRichard J Cassidy, Xinyan Zhang, Pretesh R Patel, et al.
The Journal of Molecular Diagnostics : JMD|May 8, 2016
Multi-Institutional FASTQ File Exchange as a Means of Proficiency Testing for Next-Generation Sequencing Bioinformatics and Variant InterpretationKurtis D Davies, Midhat S Farooqi, Mike Gruidl, et al.
JCI Insight|March 15, 2017
Targeting adhesion signaling in <i>KRAS, LKB1</i> mutant lung adenocarcinomaMelissa Gilbert-Ross, Jessica Konen, Junghui Koo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01Andrew B Lassman, Michael R Rossi, Jeffrey J Raizer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2015
A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non-Small Cell Lung CancerTaofeek K Owonikoko, Suresh S Ramalingam, Daniel L Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2017
The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2)Dara L Aisner, Lynette M Sholl, Lynne D Berry, et al.
The Journal of Molecular Diagnostics : JMD|January 24, 2016
Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal MalignanciesKevin E Fisher, Linsheng Zhang, Jason Wang, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Cancer Genetics|October 12, 2015
A multicenter, cross-platform clinical validation study of cancer cytogenomic arraysMarilyn M Li, Federico A Monzon, Jaclyn A Biegel, et al.
NPJ Precision Oncology|November 13, 2018
Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathwaysSameer H Halani, Safoora Yousefi, Jose Velazquez Vega, et al.
Cancer Medicine|August 16, 2014
Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancerTaofeek K Owonikoko, Guojing Zhang, Xingming Deng, et al.
Cancer|June 14, 2017
Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapyRichard J Cassidy, Xinyan Zhang, Pretesh R Patel, et al.
The Journal of Molecular Diagnostics : JMD|May 8, 2016
Multi-Institutional FASTQ File Exchange as a Means of Proficiency Testing for Next-Generation Sequencing Bioinformatics and Variant InterpretationKurtis D Davies, Midhat S Farooqi, Mike Gruidl, et al.
JCI Insight|March 15, 2017
Targeting adhesion signaling in <i>KRAS, LKB1</i> mutant lung adenocarcinomaMelissa Gilbert-Ross, Jessica Konen, Junghui Koo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01Andrew B Lassman, Michael R Rossi, Jeffrey J Raizer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2015
A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non-Small Cell Lung CancerTaofeek K Owonikoko, Suresh S Ramalingam, Daniel L Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2017
The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2)Dara L Aisner, Lynette M Sholl, Lynne D Berry, et al.
The Journal of Molecular Diagnostics : JMD|January 24, 2016
Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal MalignanciesKevin E Fisher, Linsheng Zhang, Jason Wang, et al.
Pageof 7